Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds | Zendy

Haiyan Wang | Zendy; Shasha Li | Zendy; Qianyu Wang | Zendy; Zhengshuo Jin | Zendy; Wei Shao | Zendy; Yan Gao | Zendy; Lu Li | Zendy; Kequan Lin | Zendy; Lin Zhu | Zendy; Huili Wang | Zendy; Xuebin Liao | Zendy; Dong Wang | Zendy

Open Access

Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds

Author(s) -

Haiyan Wang,

Shasha Li,

Qianyu Wang,

Zhengshuo Jin,

Wei Shao,

Yan Gao,

Lu Li,

Kequan Lin,

Lin Zhu,

Huili Wang,

Xuebin Liao,

Dong Wang

Publication year - 2021

Publication title -

science advances

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.928

H-Index - 146

ISSN - 2375-2548

DOI - 10.1126/sciadv.abd7851

Subject(s) - immunotherapy , high throughput screening , drug discovery , immune system , signature (topology) , throughput , computational biology , booster (rocketry) , phenotypic screening , phenotype , medicine , biology , computer science , immunology , bioinformatics , gene , genetics , telecommunications , physics , geometry , mathematics , astronomy , wireless

A high-throughput screening approach enables the discovery of tumor immune microenvironment modulator and immunotherapy booster.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research